Maintenance therapy with infliximab or vedolizumab in IBD is not associated with increased SARS-CoV-2 seroprevalence: UK experience in the 2020 pandemic.
Colleen Gc McGregorAlex AdamsRoss SadlerCarolina V Arancibia-CárcamoRebecca PalmerTim AmbroseOliver BrainAlissa WalshPaul KlenermanSimon P L TravisNicholas M CroftJames O LindsayJack SatsangiPublished in: Gut (2021)